Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
13 NEW May 24, 2023
When antibodies become anti-body

When antibodies become anti-body

From the Houghton and Lampe labs, Clinical Research and Public Health Sciences Divisions
Science Spotlight - February 20, 2023
MacPherson Lab puts immunologically cold cancers in the hot seat with combination therapy

MacPherson Lab puts immunologically cold cancers in the hot seat with combination therapy

From the MacPherson and Srivastava Labs, Cancer Basic Biology and Cancer Immunology Programs, Cancer Consortium.
Science Spotlight - October 17, 2022
CD133 auto-antibodies shine a light on early-stage small cell lung cancer

CD133 auto-antibodies shine a light on early-stage small cell lung cancer

From the Dr. Paul D Lampe, Dr. Christopher Li, and Dr. A McGarry Houghton Labs, Cancer Epidemiology, Prevention and Control and Cancer Immunology Programs, Cancer Consortium.
Science Spotlight - August 15, 2022
Making immunotherapy more effective against small cell lung cancer

Making immunotherapy more effective against small cell lung cancer

Human trial opens after experimental drug improves tumor growth suppression in mice
Hutch News - August 03, 2022
New insights into drug resistance in small cell lung cancer

New insights into drug resistance in small cell lung cancer

Scientists discover a single gene’s outsized role in drug resistance — and use its vulnerability to re-sensitize tumors to chemotherapy in preclinical models
Hutch News - August 20, 2020
Q&A: A new focus on small cell lung cancer

Q&A: A new focus on small cell lung cancer

Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future
Hutch News - February 07, 2019
Path to a targeted treatment for small-cell lung cancer?

Path to a targeted treatment for small-cell lung cancer?

Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs
Hutch News - September 04, 2018